ASHLEY PEDIGO: Open Payments
NPI 1851834345 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 26 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $203 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Syndax Pharmaceuticals, Inc. | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Lilly USA, LLC | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $27 |
| Acrotech Biopharma Inc. | 1 | $23 |
| ACCORD HEALTHCARE, INC. | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
Products named: ICLUSIG, REVUFORJ, VERZENIO, Xermelo, PYRUKYND, FRUZAQLA, Enhertu, BELEODAQ.
Industry payments across IN — which companies pay providers there.
